{"id":19336,"date":"2025-03-05T09:44:46","date_gmt":"2025-03-05T09:44:46","guid":{"rendered":"https:\/\/www.hotelsalepage.com\/feed\/cision-pr-newswire\/btls-emface-surpasses-1-million-treatments-becoming-the-fastest-growing-non-invasive-facial-lifting-procedure\/"},"modified":"2025-03-05T09:44:46","modified_gmt":"2025-03-05T09:44:46","slug":"btls-emface-surpasses-1-million-treatments-becoming-the-fastest-growing-non-invasive-facial-lifting-procedure-2","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=19336","title":{"rendered":"BTL’s EMFACE Surpasses 1 Million Treatments, Becoming the Fastest-Growing Non-Invasive Facial Lifting Procedure"},"content":{"rendered":"

PRAGUE<\/span><\/span>, March 5, 2025<\/span><\/span> \/PRNewswire\/ —\u00a0EMFACE, the revolutionary non-invasive facial treatment, has reached an extraordinary milestone\u2014becoming the fastest procedure of its kind to surpass 1 million treatments worldwide in just under two years. This achievement cements EMFACE as the leading non-invasive facial procedure uniquely designed to treat both the skin and underlying muscles for a more youthful, lifted appearance.<\/p>\n

\"Before<\/a>
Before and after EMFACE: After 4th treatment, courtesy of: Joel L. Cohen, M.D.<\/span> <\/div>\n

Developed by BTL, a global leader in medical technology, EMFACE transformed the industry in 2022 as the first operator-independent procedure to non-invasively target facial muscles while simultaneously improving skin quality.<\/p>\n

“The ability to stimulate elevator muscles allows us to lift facial features from within\u2014something that was never possible before with injectables or traditional energy-based devices,”<\/i> said Dr. Yael Halaas<\/span>, a facial plastic surgeon from NYC, USA<\/span>.<\/p>\n

With no needles, downtime, or discomfort, EMFACE has gained widespread recognition among both medical professionals and patients, driving its rapid adoption across the globe.<\/p>\n

Innovation at the Forefront of Success<\/b><\/p>\n

Over the past year, EMFACE has expanded its capabilities with the introduction of specialized submental and under-eye applicators, making the treatment even more versatile. The latest eye applicators received overwhelmingly positive feedback from attending medical experts upon their launch at the IMCAS World Conference in Paris<\/span> in January 2025<\/span>.<\/p>\n

“EMFACE isn’t just a procedure\u2014it’s a facial multiplatform that allows us to treat different areas based on each patient’s unique needs. It’s a game-changer for anyone looking for natural-looking facial rejuvenation,”<\/i> added Dr. Kyungkook Hong, a board-certified dermatologist from Seoul, Korea<\/span>.<\/p>\n

Global Expansion and Industry Impact<\/b><\/p>\n

EMFACE continues to gain momentum, with more practitioners integrating it into their treatment offerings. Its ability to complement injectables makes it a key component of comprehensive facial rejuvenation plans, providing patients with non-invasive solution for enhanced results.<\/p>\n

“Reaching 1 million treatments in just two years is a testament to EMFACE’s groundbreaking technology and the value it brings to medical professionals,”<\/i> said Tomas Schwarz<\/span>, CEO of BTL. “We remain committed to expanding this platform and further advancing non-invasive facial treatments in the years ahead.”<\/i><\/p>\n

For more information about EMFACE and its revolutionary technology, visit www.emface.com<\/a>.<\/p>\n

About BTL<\/b><\/p>\n

Founded in 1993, BTL has grown to become one of the world’s leading medical equipment manufacturers. With 500+ engineers and 3,000+ employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including intimate health and mental wellness. Among other brands, BTL’s products include EMSCULPT NEO\u00ae<\/sup>, EMFACE\u00ae<\/sup>, EXION\u2122, EMSELLA\u00ae<\/sup>, EXOMIND\u2122 as well as their proprietary HIFEM\u00ae<\/sup>, HIFES\u2122 and EXOTMS\u2122 procedures. Please visit www.btlaesthetics.com<\/a>\u00a0for additional information.<\/p>\n

\u00a0<\/p>","protected":false},"excerpt":{"rendered":"

<\/p>\n

PRAGUE<\/span><\/span>, March 5, 2025<\/span><\/span> \/PRNewswire\/ —\u00a0EMFACE, the revolutionary non-invasive facial treatment, has reached an extraordinary milestone\u2014becoming the fastest procedure of its kind to surpass 1 million treatments worldwide in just under two years. This achievement cements EMFACE as the leading non-invasive facial procedure uniquely designed to treat both the skin and underlying muscles for a more youthful, lifted appearance.<\/p>\n

\"Before<\/a>
Before and after EMFACE: After 4th treatment, courtesy of: Joel L. Cohen, M.D.<\/span> <\/div>\n

Developed by BTL, a global leader in medical technology, EMFACE transformed the industry in 2022 as the first operator-independent procedure to non-invasively target facial muscles while simultaneously improving skin quality.<\/p>\n

“The ability to stimulate elevator muscles allows us to lift facial features from within\u2014something that was never possible before with injectables or traditional energy-based devices,”<\/i> said Dr. Yael Halaas<\/span>, a facial plastic surgeon from NYC, USA<\/span>.<\/p>\n

With no needles, downtime, or discomfort, EMFACE has gained widespread recognition among both medical professionals and patients, driving its rapid adoption across the globe.<\/p>\n

Innovation at the Forefront of Success<\/b><\/p>\n

Over the past year, EMFACE has expanded its capabilities with the introduction of specialized submental and under-eye applicators, making the treatment even more versatile. The latest eye applicators received overwhelmingly positive feedback from attending medical experts upon their launch at the IMCAS World Conference in Paris<\/span> in January 2025<\/span>.<\/p>\n

“EMFACE isn’t just a procedure\u2014it’s a facial multiplatform that allows us to treat different areas based on each patient’s unique needs. It’s a game-changer for anyone looking for natural-looking facial rejuvenation,”<\/i> added Dr. Kyungkook Hong, a board-certified dermatologist from Seoul, Korea<\/span>.<\/p>\n

Global Expansion and Industry Impact<\/b><\/p>\n

EMFACE continues to gain momentum, with more practitioners integrating it into their treatment offerings. Its ability to complement injectables makes it a key component of comprehensive facial rejuvenation plans, providing patients with non-invasive solution for enhanced results.<\/p>\n

“Reaching 1 million treatments in just two years is a testament to EMFACE’s groundbreaking technology and the value it brings to medical professionals,”<\/i> said Tomas Schwarz<\/span>, CEO of BTL. “We remain committed to expanding this platform and further advancing non-invasive facial treatments in the years ahead.”<\/i><\/p>\n

For more information about EMFACE and its revolutionary technology, visit www.emface.com<\/a>.<\/p>\n

About BTL<\/b><\/p>\n

Founded in 1993, BTL has grown to become one of the world’s leading medical equipment manufacturers. With 500+ engineers and 3,000+ employees in over 80 countries, BTL offers advanced non-invasive solutions for body-shaping, skin-tightening, and other medical aesthetic treatments, including intimate health and mental wellness. Among other brands, BTL’s products include EMSCULPT NEO\u00ae<\/sup>, EMFACE\u00ae<\/sup>, EXION\u2122, EMSELLA\u00ae<\/sup>, EXOMIND\u2122 as well as their proprietary HIFEM\u00ae<\/sup>, HIFES\u2122 and EXOTMS\u2122 procedures. Please visit www.btlaesthetics.com<\/a>\u00a0for additional information.<\/p>\n

\u00a0<\/p>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-19336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/19336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19336"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/19336\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}